Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 42
- Next page
Title | Authors | Year | Journal | Link to Article | Intended Audience Sort descending | Purpose |
---|---|---|---|---|---|---|
Trends in platelet distributions from 2008 to 2017: a survey of twelve national and regional blood collectors | Yazer MH, Shaz B, Seheult JN, Apelseth TO, de Korte D, Devin G, Devine D, Doncaster C, Field S, Flanagan P, Huet J, Mendrone Jr A, O’Brien C, Pink J, Rashleigh M, Shinar E, Takanashi M, Tian E, Tiberghien P, van den Berg K, Schmitt C | 2020 | Vox Sang | View Trends in platelet distributions from 2008 to 2017: a survey of twelve national and regional blood collectors | Blood operators | Benchmarking and standard setting |
Research partnerships between blood services and public health authorities: An international, cross-sectional survey | Lewin A, Osiowy C, Erikstrup C, Custer B, Renaud C, Tiberghien P, Russell A, Lieshout-Krikke R, O'Brien SF, the Surveillance Risk Assessment Policy Sub-group of the ISBT Transfusion Transmitted Infectious Diseases Working Party | 2022 | Vox Sang | View Research partnerships between blood services and public health authorities: An international, cross-sectional survey | Blood operators | Benchmarking and standard setting |
Aggregates in platelet concentrates | van der Meer PF, Dumont LJ, Lozano M, Bondar N, Wong J, Ismay S, Pink J, Nussbaumer W, Coene J, Feys HB, Compernolle V, Devine DV, Howe D, Lin CK, Sun J, Ringwald J, Strasser EF, Eckstein R, Seltsam A, Perseghin P, Proserpio P, Wakamoto S, Akino M, Takamoto S, Tadokoro K, Teo D, Shu PH, Chua SS, Jimenez-Marco T, Lozano M, Cid J, Castro E, Munoz I, Gulliksson H, Sandgren P, Thomas S, Petrik J, McColl K, Kamel H, Dugger J, Sweeney JD, Gorlin JB, Sutor LJ, Heath D, Sayers MH | 2015 | Vox Sang | View Aggregates in platelet concentrates | Blood operators | Benchmarking and standard setting |
Deja-vu all over again: using simulation to evaluate the impact of shorter shelf life for red blood cells at Hema-Quebec | Blake JT, Hardy M, Delage G, Myhal G | 2013 | Transfusion | View Deja-vu all over again: using simulation to evaluate the impact of shorter shelf life for red blood cells at Hema-Quebec | Blood operators | New or improved product or process |
Implementation and public acceptability: lessons from food irradiation and how they might apply to pathogen reduction in blood products | Heddle NM, Lane SJ, Sholapur N, Arnold E, Newbold B, Eyles J, Webert KE | 2014 | Vox Sang | View Implementation and public acceptability: lessons from food irradiation and how they might apply to pathogen reduction in blood products | Blood operators | Other |
Seroprevalence of Babesia microti infection in Canadian blood donors | O'Brien SF, Delage G, Scalia V, Lindsay R, Bernier F, Dubuc S, Germain M, Pilot G, Yi Q-L, Fearon MA | 2016 | Transfusion | View Seroprevalence of Babesia microti infection in Canadian blood donors | Blood operators | New or improved product or process |
Vox Sanguinis international forum on platelet cryopreservation: summary | Cohn CS, Dumont LJ, Lozano M, Marks D, Johnson L, Ismay S, Bondar N, T'Sas F, Yokoyama APH, Kutner JM, Acker J, Bohonek M, Sailliol A, Martinaud C, Poglod R, Antoniewicz-Papis J, Lachert E, Pun P, Lu J, Cid J, Guijarro F, Puig L, Gerber B, Alberio L, Schanz U, Buser A, Noorman F, Zoodsma M, van der Meer PF, de Korte D, Wagner S, O'Neill M | 2017 | Vox Sang | View Vox Sanguinis international forum on platelet cryopreservation: summary | Blood operators | New or improved product or process |
Development and evaluation of stem cell collection procedure diagrams to support the education and recruitment of committed stem cell donors | Fingrut W, Cuperfain AB, Chan SWS, Ptak E, Kahlon M, Dhaliwal J, Naidu A, Wang YG, Baribeau O, Mahmoudi T, Lee A, Suppiah R, Luo OD, Green M, Weiss JT, Mercer D, Elmoazzen H, Petraszko T, Allan D | 2020 | Vox Sang | View Development and evaluation of stem cell collection procedure diagrams to support the education and recruitment of committed stem cell donors | Blood operators | New or improved product or process |
International Forum on Walking Blood Bank Programmes: Responses | Martinaud C, Scorer T, Lozano M, Miles A, Fitchett G, Ba A, Wikman A, Nimberger-Hansson P, Enbuske S, Bohon?k M, Devine D, Beckett AN, Mbanya D, T'Sas F, Degueldre J, Chueca M, Dedome E, Apelseth T, Strandenes G, Wendel S, Fachini R, Olszewski A, Dupont C, Glassberg E, Shinar E, Taylor AL, Corley JB, Nadarajan VS, Dunbar N | 2021 | Vox Sang | View International Forum on Walking Blood Bank Programmes: Responses | Blood operators | New or improved product or process |
Impact of product platelet count reduction on platelet demand in Canada | Devine DV | 2022 | Transfusion | View Impact of product platelet count reduction on platelet demand in Canada | Blood operators | Benchmarking and standard setting |
Biofilm formation by Staphylococcus capitis strains isolated from contaminated platelet concentrates | Greco-Stewart VS, Ali H, Kumaran D, Kalab M, Rood IG, de Korte D, Ramirez-Arcos S | 2013 | J Med Microbiol | View Biofilm formation by Staphylococcus capitis strains isolated from contaminated platelet concentrates | Blood operators | Basic research |
Iron status in Canadian Blood Services Donors | Goldman M | 2014 | Blood.ca website | View Iron status in Canadian Blood Services Donors | Blood operators | Clinical research |
Pathogen Inactivation Technologies: The Advent of Pathogen-Reduced Blood Components to Reduce Blood Safety Risk | Devine DV, Schubert P | 2016 | Hematol Oncol Clin North Am | View Pathogen Inactivation Technologies: The Advent of Pathogen-Reduced Blood Components to Reduce Blood Safety Risk | Blood operators | Other |
Quality of frozen transfusable plasma prepared from whole blood donations in Canada: An update | Sheffield WP, Bhakta V, Talbot K, Pryzdial ELG, Jenkins C | 2013 | Transfus Apher Sci | View Quality of frozen transfusable plasma prepared from whole blood donations in Canada: An update | Blood operators | Benchmarking and standard setting |
Buffy coat platelets coming to America: Are we ready? | Gammon RR, Devine D, Katz LM, Quinley E, Wu Y, Rowe K, Razatos A, Min K, Reichenberg S, Smith R | 2021 | Transfusion | View Buffy coat platelets coming to America: Are we ready? | Blood operators | New or improved product or process |
Trans people and blood donation | Goldman M, Butler-Foster T, Lapierre D, O'Brien SF, Devor A | 2020 | Transfusion | View Trans people and blood donation | Blood operators | New or improved product or process |
ResearchUnit: Sexual behaviour-based screening questions: Understanding and mitigating donor discomfort | Woo H | 2022 | Blood.ca website | View ResearchUnit: Sexual behaviour-based screening questions: Understanding and mitigating donor discomfort | Blood operators | MSM research |
Use of selective phenotyping and genotyping to identify rare blood donors in Canada | Tordon B, Montemayor C, Clarke G, O'Brien SF, Goldman M | 2023 | Vox Sang | View Use of selective phenotyping and genotyping to identify rare blood donors in Canada | Blood operators | Clinical research |
Storage duration and other measures of quality of red blood cells for transfusion | Spinella PC, Acker J | 2015 | JAMA | View Storage duration and other measures of quality of red blood cells for transfusion | Blood operators | Other |
Delayed clamping of the umbilical cord after delivery and implications for public cord blood banking | Allan DS, Scrivens N, Lawless T, Mostert K, Oppenheimer L, Walker M, Petraszko T, Elmoazzen H | 2015 | Transfusion | View Delayed clamping of the umbilical cord after delivery and implications for public cord blood banking | Blood operators | Other |
Implementation of pathogen inactivation technology: How to make the best decisions? | Devine DV | 2017 | Transfusion | View Implementation of pathogen inactivation technology: How to make the best decisions? | Blood operators | New or improved product or process |
Serratia marcescens strains implicated in adverse transfusion reactions form biofilms in platelet concentrates and demonstrate reduced detection by automated culture | Greco-Stewart VS, Brown EE, Parr C, Kalab M, Jacobs MR, Yomtovian RA, Ramirez-Arcos SM | 2012 | Vox Sang | View Serratia marcescens strains implicated in adverse transfusion reactions form biofilms in platelet concentrates and demonstrate reduced detection by automated culture | Blood operators | Basic research |
Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use | Morton S, Stanworth S, Lozano M, Harrison SJ, Hong FS, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner JM, Yokoyama APH, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze TJ, Bux J, Pierelli L, Ballester C, Netelenbos T, West KA, Conry?Cantilena C, Eder A, Haley NR, Yazer M, Triulzi D | 2017 | Vox Sang | View Vox Sanguinis International Forum on provision of granulocytes for transfusion and their clinical use | Blood operators | Clinical research |
Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic | Wendel S, Land K, Devine DV, Daly J, Bazin R, Tiberghien P, Lee C-K, Arora S, Patidar GK, Khillan K, Smid WM, Vrielink H, Oreh A, Al-Riyami AZ, Hindawi S, Vermeulen M, Louw V, Burnouf T, Bloch EM, Goel R, Townsend M, So-Osman C | 2021 | Vox Sang | View Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic | Blood operators | New or improved product or process |
International Forum on Walking Blood Bank Programmes: Summary | Martinaud C, Scorer T, Lozano M, Miles A, Fitchett G, Ba A, Wikman A, Nimberger-Hansson P, Enbuske S, Bohon?k M, Devine D, Beckett AN, Mbanya D, T'Sas F, Degueldre J, Chueca M, Dedome E, Apelseth T, Strandenes G, Wendel S, Fachini R, Olszewski A, Dupont C, Glassberg E, Shinar E, Taylor AL, Corley JB, Sekaran Nadarajan V, Dunbar N | 2021 | Vox Sang | View International Forum on Walking Blood Bank Programmes: Summary | Blood operators | Benchmarking and standard setting |
Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID-19 pandemic: A Canadian Blood Services Stem Cell Registry analysis | Allan DS, Green M, Morris G, Weiss J, Dibdin N, Mercer D, Seftel M | 2022 | Vox Sang | View Demand and usage of unrelated donor products for allogeneic haematopoietic cell transplantation during the COVID-19 pandemic: A Canadian Blood Services Stem Cell Registry analysis | Blood operators | Clinical research |
Alternative methods of blood donor skin disinfection | Ramirez-Arcos S, Taha M, Kou Y, Goldman M | 2017 | Blood.ca website | View Alternative methods of blood donor skin disinfection | Blood operators | New or improved product or process |
Biofilm-forming skin microflora bacteria are resistant to the bactericidal action of disinfectants used during blood donation | Taha M, Kalab M, Yi QL, Landry C, Greco-Stewart V, Brassinga AK, Sifri CD, Ramirez-Arcos S | 2014 | Transfusion | View Biofilm-forming skin microflora bacteria are resistant to the bactericidal action of disinfectants used during blood donation | Blood operators | New or improved product or process |
Determining recruiting strategies for an adult stem cell registry | Blake JT, McTaggart K, Killeen D | 2016 | Oper Res Health Care | View Determining recruiting strategies for an adult stem cell registry | Blood operators | New or improved product or process |
Donor attention to reading materials | O'Brien SF, Osmond L, Choquet K, Yi QL, Goldman M | 2015 | Vox Sang | View Donor attention to reading materials | Blood operators | Other |
Evaluation of the BacT/ALERT 3D system for the implementation of in-house quality control sterility testing at Canadian Blood Services | Mastronardi C, Perkins H, Derksen P, denAdmirant M, Ramirez-Arcos S | 2010 | Clin Chem Lab Med | View Evaluation of the BacT/ALERT 3D system for the implementation of in-house quality control sterility testing at Canadian Blood Services | Blood operators | New or improved product or process |
Mitigation of the threat posed to transfusion by donors traveling to Zika-affected areas: a Canadian risk-based approach | Germain M, Delage G, O'Brien SF, Grégoire Y, Fearon M, Devine D | 2017 | Transfusion | View Mitigation of the threat posed to transfusion by donors traveling to Zika-affected areas: a Canadian risk-based approach | Blood operators | Clinical research |
Development of standard definitions for surveillance of complications related to blood donation | Goldman M, Land K, Robillard P, Wiersum-Osselton J | 2016 | Vox Sang | View Development of standard definitions for surveillance of complications related to blood donation | Blood operators | Benchmarking and standard setting |
From Development to Implementation: Adjusting the Hematocrit of Deglycerolized Red Cell Concentrates to Meet Regulatory Standards | Turner T, Hansen A, Kurach J, Acker JP | 2017 | Transfus Med Hemother | View From Development to Implementation: Adjusting the Hematocrit of Deglycerolized Red Cell Concentrates to Meet Regulatory Standards | Blood operators | Benchmarking and standard setting |
Impact of changes to policy for Mexican risk travel on Canadian blood donor deferrals | O'Brien SF, Uzicanin S, Choquet K, Yi QL, Fan W, Goldman M | 2013 | Blood Transfus | View Impact of changes to policy for Mexican risk travel on Canadian blood donor deferrals | Blood operators | New or improved product or process |
Proceedings of a Consensus Conference: Risk-Based Decision Making for Blood Safety | Leach Bennett J, Blajchman MA, Delage G, Fearon M, Devine D | 2011 | Transfus Med Rev | View Proceedings of a Consensus Conference: Risk-Based Decision Making for Blood Safety | Blood operators | Other |
SARS in Canada: Lessons learned for the blood operator | Devine DV | 2020 | Transfus Med | View SARS in Canada: Lessons learned for the blood operator | Blood operators | Other |
Current Understanding of the Relationship between Blood Donor Variability and Blood Component Quality | Hadjesfandiari N, Khorshidfar M, Devine DV | 2021 | Int J Mol Sci | View Current Understanding of the Relationship between Blood Donor Variability and Blood Component Quality | Blood operators | New or improved product or process |
Lessons Learned from the COVID-19 Pandemic and How Blood Operators Can Prepare for the Next Pandemic | Drews SJ, O’Brien SF | 2022 | Viruses | View Lessons Learned from the COVID-19 Pandemic and How Blood Operators Can Prepare for the Next Pandemic | Blood operators | New or improved product or process |
Bacterial contamination in platelet concentrates | Pietersz RNI, Reesink HW, Panzer S, Oknaian S, Kuperman S, Gabriel C, Rapaille A, Lambermont M, Deneys V, Sondag D, Ramirez-Arcos S, Goldman M, Delage G, Bernier F, Germain M, Vuk T, Georgsen J, Morel P, Naegelen C, Bardiaux L, Cazenave JP, Dreier J, Vollmer T, Knabbe C, Seifried E, Hourfar K, Lin CK, Spreafico M, Raffaele L, Berzuini A, Prati D, Satake M, de Korte D, van der Meer PF, Kerkhoffs JL, Blanco L, Kjeldsen-Kragh J, Svard-Nilsson AM, McDonald CP, Symonds I, Moule R, Brailsford S, Yomtovian R, Jacobs MR | 2014 | Vox Sang | View Bacterial contamination in platelet concentrates | Blood operators | Benchmarking and standard setting |
Vox Sanguinis international forum on provision of granulocytes for transfusion and their clinical use: summary | Morton S, Stanworth S, Lozano M, Harrison S, Hong F, Dennington P, McQuilten Z, Worel N, Compernolle V, Kutner J, Yokoyama A, Nahirniak S, Germain M, Hume H, Robitaille N, Wilson A, Tinmouth A, Massey E, Boulat C, Woimant G, Tiberghien P, Schulze T, Bux J, Pierelli L, Ballester C, Netelenbos T, West K, Conry-Cantilena C, Eder A, Haley N, Yazer M, Triulzi D | 2017 | Vox Sang | View Vox Sanguinis international forum on provision of granulocytes for transfusion and their clinical use: summary | Blood operators | Clinical research |
Alternatives in blood operations when choosing non-DEHP bags | van der Meer PF, Devine DV, on behalf of the BEST Collaborative | 2017 | Vox Sang | View Alternatives in blood operations when choosing non-DEHP bags | Blood operators | New or improved product or process |
Determining staffing requirements for blood donor clinics: the Canadian Blood Services experience | Blake JT, Shimla S | 2014 | Transfusion | View Determining staffing requirements for blood donor clinics: the Canadian Blood Services experience | Blood operators | New or improved product or process |
Donor criteria for men who have sex with men: a Canadian perspective | Goldman M, Lapierre D, Lemay L, Devine D, Sher G | 2014 | Transfusion | View Donor criteria for men who have sex with men: a Canadian perspective | Blood operators | Benchmarking and standard setting |
Evaluation of the sterility testing process of hematopoietic stem cells at Canadian Blood Services | Mastronardi C, Yang L, Halpenny M, Toye B, Ramirez-Arcos S | 2012 | Transfusion | View Evaluation of the sterility testing process of hematopoietic stem cells at Canadian Blood Services | Blood operators | New or improved product or process |
Pathogen reduction technologies: The pros and cons for platelet transfusion | Magron A, Laugier J, Provost P, Boilard E | 2018 | Platelets | View Pathogen reduction technologies: The pros and cons for platelet transfusion | Blood operators | Basic research |
Using simulation for strategic blood supply chain design in the Canadian prairies | Blake J, McTaggart K | 2016 | Proceedings of the 6th International Conference on SIMULTECH | View Using simulation for strategic blood supply chain design in the Canadian prairies | Blood operators | New or improved product or process |
An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers | Lewin A, Drews SJ, Lieshout-Krikke R, Erikstrup C, Saeed S, Fady H, Uzicanin S, Custer B, O’Brien SF, the Surveillance Risk Assessment Policy tVS-gotI, Transfusion Transmitted Infectious Diseases Working Party | 2021 | Vox Sang | View An international comparison of anti-SARS-COV-2 assays used for seroprevalence surveys from blood component providers | Blood operators | Benchmarking and standard setting |
The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study | Cho JH, Rajbhandary S, van Buren NL, Fung MK, Al-Ghafry M, Fridey JL, Dy BA, Ziman A, Schreiber GB, Gammon RR, Reik R, Stubbs JR, van Buskirk CM, Kamel H, Townsend MJ, Zeller MP, Gottschall JL | 2021 | Transfusion | View The safety of COVID-19 convalescent plasma donation: A multi-institutional donor hemovigilance study | Blood operators | Benchmarking and standard setting |
HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men | Aubé E, Lewin A, O'Brien SF, Grégoire Y, Pillonel J, Steele WR, Custer B, Davison KL, Germain M, Seed CR, Camirand Lemyre F, the Surveillance RA, Policy Subgroup of the ISBT Transfusion Transmitted Infectious Diseases Working Party | 2022 | Vox Sang | View HIV residual risk in Canada for apheresis source plasma donation without deferral for men who have sex with men | Blood operators | MSM research |